- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Empaglifozin placebo Linagliptin placebo
Total 53855 results
-
Oslo University HospitalVestre Viken Hospital Trust; University of Oslo; The Research Council of Norway; University Hospital, Akershus and other collaboratorsRecruitingGlucose Metabolism Disorders | Impaired Glucose Tolerance | Insulin SensitivityNorway
-
JW PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
McGill University Health Centre/Research Institute...Diabetes CanadaRecruiting
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2China
-
Boehringer IngelheimEli Lilly and CompanyCompletedMyocardial InfarctionUnited States, Spain, Australia, Denmark, Netherlands, Canada, China, Germany, Korea, Republic of, Israel, Hungary, Japan, Argentina, France, Romania, Russian Federation, Serbia, Ukraine, Poland, India, Brazil, Bulgaria
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United States, United Kingdom, Canada, Italy, Hungary, Spain, Sweden, Australia, Netherlands, France, Czechia, Finland, Germany, Greece, Ireland, Latvia, Mexico, New Zealand, Norway, Poland, Portugal, Romania, Russian Federation, South...
-
Daiichi Sankyo, Inc.CompletedType 2 Diabetes MellitusUnited States, Canada
-
CHEOL WHAN LEE, M.D., Ph.DCompletedCoronary Disease | Diabetes MellitusKorea, Republic of
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Boehringer IngelheimEli Lilly and Company; Medical Research Council Population Health Research...Active, not recruitingChronic Kidney DiseaseUnited States, Canada, United Kingdom, China, Germany, Italy, Japan, Malaysia
-
Oslo University HospitalCompletedDiabetes Mellitus | Renal Insufficiency | Safety IssuesNorway
-
Boehringer IngelheimCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Austria, Greece, Hungary, Japan, Portugal, Romania, Spain
-
University at BuffaloWithdrawn
-
Oregon State UniversitySamaritan Health ServicesRecruitingPreDiabetes | Prediabetic State | Overweight and ObesityUnited States
-
University of PisaCompletedEnd Stage Renal DiseaseItaly
-
University Hospital, Basel, SwitzerlandCompletedInappropriate ADH SyndromeSwitzerland
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Greater Washington Community FoundationTerminated
-
Novartis PharmaceuticalsCompletedA Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)Homozygous Familial HypercholesterolemiaHong Kong, Israel, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine
-
Rigshospitalet, DenmarkRecruiting
-
Johannes Gutenberg University MainzBoehringer IngelheimCompletedDiabetes Mellitus, Type 2 | Diastolic DysfunctionGermany
-
Unity Health TorontoBoehringer IngelheimUnknownCardiovascular Disease | DiabetesCanada
-
Woman'sMerck Sharp & Dohme LLCCompletedDisorder of Glucose RegulationUnited States
-
Boehringer IngelheimCompleted
-
Steno Diabetes Center CopenhagenUniversity of CopenhagenCompletedType 2 Diabetes | Maturity-Onset Diabetes of the Young, Type 3Denmark
-
University Hospital, Gentofte, CopenhagenCompletedType2 DiabetesDenmark
-
TakedaCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Korea, Republic of, China, Germany, Belgium, Australia, Singapore, Canada, Italy, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, United Kingdom, Mexico, Romania, Brazil, India, South Africa, Colombia
-
Novartis PharmaceuticalsTerminatedDiabetes Mellitus and Heart FailureUnited States, Belgium, Austria, Croatia, Czechia, Netherlands, Canada, Korea, Republic of, Taiwan, Hungary, United Kingdom, Italy, Bulgaria, Germany, Argentina, Ireland, Norway, Spain, Denmark, Singapore, South Africa, Mexico, Poland, Puerto Rico
-
Jichi Medical UniversityEli Lilly and Company; Boehringer IngelheimCompletedT2DM (Type 2 Diabetes Mellitus) | Nocturnal HypertensionJapan
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Yale UniversityBoehringer IngelheimCompletedHeart Failure | Type II; DiabetesUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedObesity | Diabetes Mellitus, Type 2United States, Belgium, Bulgaria, Colombia, Czech Republic, Finland, France, Germany, Guatemala, Mexico, Peru, Russian Federation, Spain, Ukraine
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Renal InsufficiencyUnited States, Canada, France, Hong Kong, India, Malaysia, Netherlands, Philippines, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, United Kingdom
-
Eli Lilly and CompanyBerry Consultants; United BioSource, LLC; Tessella Inc.CompletedDiabetes Mellitus, Type 2United States, Korea, Republic of, Russian Federation, Puerto Rico, Romania, Spain, Taiwan, Mexico, France, Germany, India, Canada, Poland
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
Contera PharmaBukwang PharmaceuticalActive, not recruitingDyskinesiasFrance, Germany, Italy, Korea, Republic of, Spain
-
University of California, San DiegoTerminated
-
NovartisCompletedAcute Blunt Soft Tissue Injuries/ContusionsUnited States
-
Fengmei LianPeking Union Medical College Hospital; Huashan Hospital; Chengdu University of... and other collaboratorsUnknownDiabetic Peripheral Neuropathy Type 2China
-
William Beaumont HospitalsTerminatedFibrosis, Liver | Cirrhosis, Liver | Steatohepatitis, Nonalcoholic | Fatty Liver DiseaseUnited States
-
Vanderbilt UniversityMerck Sharp & Dohme LLCWithdrawnPeripheral Artery Disease
-
Boehringer IngelheimNot yet recruiting
-
Unity Health TorontoBoehringer Ingelheim; Canadian Medical and Surgical Knowledge Translation Research... and other collaboratorsCompletedCardiovascular Diseases | Left Ventricular HypertrophyCanada, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Korea, Republic of, China, Germany, Belgium, Australia, Italy, United Kingdom, Argentina, Hungary, Czechia, Poland, Netherlands, Japan, Mexico, India, Brazil, France
-
Boehringer IngelheimEli Lilly and CompanyCompletedHeart FailureUnited States, Spain, Canada, Germany, Greece, Australia, Sweden, Italy, Norway, Poland, Portugal